ClinicalTrials.Veeva

Menu

Non Interventional Study In Bipolar Disorder And Schizophrenia With Zeldox

Viatris logo

Viatris

Status

Completed

Conditions

Schizophrenia
Bipolar Disorder

Treatments

Other: no intervention

Study type

Observational

Funder types

Industry

Identifiers

NCT00538629
A1281171

Details and patient eligibility

About

Investigation of the impact of Zeldox on metabolic parametres in patients with bipolar disorder or with schizophrenia and impact of the treatment for the quality of life

Full description

observational survey consecutive patient sampling

Enrollment

471 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Manic and mixed episodes of up to moderate severity in patients with type I and II bipolar disorder and schizophrenia; either first diagnosed or repeated episodes.

Exclusion criteria

Patients with a history of hypersenzitivity to Ziprasidone. Previous insufficiency of the Ziprasidone´s treatment. The break of the previous therapeutic condition.

Trial design

471 participants in 2 patient groups

schizophrenic
Description:
patients with schizophrenia
Treatment:
Other: no intervention
Other: no intervention
bipolar disorder
Description:
patients with bipolar disorder
Treatment:
Other: no intervention
Other: no intervention

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems